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PyrimidineAbstract The molecular modelling approach was applied to a series of nineteen curcumin ana-
logues to ﬁnd the possible PfRIO2 kinase inhibitory action. A putative active site in ﬂexible loop
(S1) of PfRIO2 kinase was explored computationally to recognize the molecular basis of ligands
binding. The ligands (curcumin analogues; 3a–3s) were well accommodated in the selected active
site (S1) due to their higher molecular size and length. Further all these synthesized compounds
(3a–3s) were evaluated for their in vitro antimalarial activity according to the reported method.
The antimalarial data showed that all these compounds to have parasiticidal activity with minimum
killing concentrations (MKCs) range between 3.87 and 25.35 lM and schizonticidal activity with
IC50 range between 1.48 and 23.09 lM. The compound 3p showed the most signiﬁcant result
with maximum schizonticidal (IC50; 1.48 ± 0.10 lM) and parasiticidal activities (MKC;
3.87 ± 0.36 lM) could be identiﬁed as promising lead for further investigations.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf of King SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Malaria is a life-threatening disease caused by ﬁve species of
parasites and is transmitted through vector infected mosquitoof genus Anopheles. An estimated 3.4 billion people are at risk
of malaria and there are 107 countries and territories, where
malaria is endemic. As per WHO report nearly 207 million
cases of malaria and 627,000 death tolls occurred globally in
2012. Most of the cases and deaths occurred in unhygienic
and developing African countries (WHO malaria report,
2013). Artemisinin combination therapy (ACTs) has been of
much importance over the last decade however emergence of
resistance has been reported in Cambodia’s Pailin province
(WHO malaria report, 2013; Phyo et al., 2012; Kumar et al.,
2005) provides motivation to discover new potential anti-
malarial agents. More than 65 protein kinases (PKs) have been
reported in the parasite kinome with ambiguous cellular targetclic ring.
Table 1 The glide score and E-model scores of the curcumin
analogues (3a–s).
Compound Glide score E-model score
3a 4.056 59.44
3b 4.043 66.065
3c 4.404 60.514
3d 4.763 61.244
3e 5.335 65.602
3f 5.289 66.196
3g 5.457 61.647
3h 5.861 60.231
3i 6.057 66.997
3j 5.236 72.968
3k 5.618 76.206
3l 5.442 67.377
3m 5.831 61.797
3n 5.486 63.268
3o 5.893 74.414
3p 4.213 55.798
3q 5.244 60.119
3r 5.719 63.754
3s 5.628 66.947
Chloroquine 4.959 48.716
2 S.N. Balaji et al.and physiological role (Nag et al., 2013a,b). RIO-1
(PFL1490w) and RIO-2 (PFD0975w), RIO like kinases are
present in malaria kinome with uncharacterized functions
(www.plasmodb.org). The structural characterization of
RIO-2 kinase of Plasmodium falciparum (PfRIO-2 kinase)
explored having N-terminal DNA binding winged helix
domain, a linker region and C-terminal kinase domain
together with well deﬁned ATP binding pocket with signiﬁ-
cantly different than that of the human RIO-2 kinase
(Trivedi and Nag, 2012).
It has been observed that natural products from plants and
their synthetic, semi synthetic analogues are expected to play
an imperative role in creating new and better chemotherapeu-
tic agents. Artemisinin, a natural product and their semi-syn-
thetic analogues are included in the ﬁrst line treatment of
malaria caused by dreadful species, P. falciparum. Another
product from natural source was quinine which is another
therapeutic approach in the treatment of malaria.
Febrifugine, apigenin, and argentilactones are other natural
products reported with high antimalarial activity (Koepﬂi
et al., 1947; Carmona et al., 2003). Curcumin is a b-diketone
obtained from the powdered root of Curcuma longa Linn.,
showed synergistic effect with artemisinin against
Plasmodium berghei in vivo (Reddy et al., 2005;
Nandakumar et al., 2006). It is also potent against both
chloroquine susceptible and resistant strains of P. falciparum
and exerted parasiticidal effect (Cui et al., 2007). Medicinal
chemists have exploited four sites for chemical modiﬁcation
of curcumin, aryl side chain, diketo group, double bonds,
and active methylene group and synthesized a number of cur-
cumin analogues with improved biological activity. In the pre-
sent investigation we report herein the modiﬁcation of diketo
group to pyrazole and pyrimidine heterocycles and their anti-
malarial activity. The molecular modelling approach was
applied to these nineteen curcumin analogues to ﬁnd the pos-
sible PfRIO2 kinase inhibitory action. Apart from molecular
docking studies other possibilities such as optimized geome-
tries, energies, spatial distribution, position of the highest
occupied molecular orbital (HOMO) and the lowest unoccu-
pied molecular orbital (LUMO), and quantitative structure
activity relationship (QSAR) studies including structural and
electronic properties could be applied to study the compounds’
efﬁcacy theoretically (Ibrahim and El-Haes, 2005; Ibrahim and
Koglin, 2005; Hameed et al., 2007; Ess et al., 2008; Ibrahim
et al., 2006, 2010, 2012; Saleh et al., 2014; Okasha et al.,
2015). Various other biological activities, viz. anticancer
(Ahsan et al., 2013; Liang et al., 2009; Jia et al., 2009), antibac-
terial (Lal et al., 2012; Sahu et al., 2012; Zhichang et al., 2012),
anti-HIV (Singh et al., 2010), anti-inﬂammatory (Saja et al.,
2007), antimalarial (Mishra et al., 2008), and many more have
been reported for curcumin analogues. These recent develop-
ments made curcumin as an ideal lead compound for future
drug discovery.
2. Results and discussion
2.1. Molecular modelling
The three dimensional structure of PfRIO2 kinase with four
different binding sites namely S1–S4 was reported with several
important active site residues. The ligand docking studies byPlease cite this article in press as: Balaji, S.N. et al., Molecular modelling, synthesis,
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.011choosing S1 and S2 sites of PfRIO2 have been studied earlier
(Nag et al., 2013a,b; http://www.plasmodb.org; Parveen
et al., 2013; Nag et al., 2013a). It might be due to closeness
of S1 site with DNA binding site and S2 site with ATP. The
S1 site was employed for the current ligand docking studies.
The selected S1 site is comprised of the active site residues
includes Trp26, Ser128, Lys131, Asp137, Leu141, His142,
Tyr138, Lys135, Glu134, Val132, Arg136, Lys133, Thr127,
Leu146, Arg149, Val145 and Ile148, and later it was found that
is matching with earlier reported studies (Nag et al., 2013a,b;
www.plasmodb.org; Parveen et al., 2013; Nag et al., 2013a)
The S1 site is present at loop region which is ﬂexible in nature.
However, the present molecular docking studies of the cur-
cumin analogues revealed that the binding mode is slightly dif-
ferent from earlier reported (Parveen et al., 2013). Due to
higher molecular size and length of the curcumin analogues
they occupied the selected active site (S1) totally. The overall
major receptor interactions of all ligands observed were the
p p interactions of His142 with one of the aromatic rings
and sometimes along with aniline portion of the ligands.
Val132 was the major residues that contributed its backbone
with methoxy functional group present on the aromatic ring
and Tyr26 exhibited the similar interactions with one or two
ligands. p-Cationic interactions with Arg149 and Lys131 were
found with the aniline part and pyrazole ring of the ligands.
The Arg152 was present at another end of the ligands and
was responsible for side chain H-bonding with methoxy func-
tional group of aromatic ring repeatedly. The pyrazole bearing
aromatic rings were observed to be present near to the DNA
binding region of the protein. The docking studies ﬁnally sug-
gested that the inhibitory activity of the current compounds
may be due to interfering with normal functioning of the
PfRIO2 kinase. The docking scores are given in the Table 1.
The docking scores of the curcumin analogues reported herein
showed more afﬁnity towards PfRIO2 kinase than that of
standard antimalarial drug chloroquine. The binding mode
of all the ligands with the active site of PfRIO2 kinase is shownand antimalarial potentials of curcumin analogues containing heterocyclic ring.
Site 2 (ATP binding region)
Site 1 (Flexible loop region) 
Site 4
Site 4 
a 
− interactions 
of His142 with one 
of the aromatic ring
H-bonding with 
methoxy functional 
group of aromatic ring
Backbone with 
methoxy functional 
group of the 
aromatic ring
c 
Site 1 (Flexible loop region
binding with ligand 3p
b d
Figure 1 (a). PfRIO-2 kinase and various site and ligands (3a–s) binding at site 1 (S1). (b). The binding mode of all the ligands (3a–s)
with the active site of PfRIO2 kinase and interactions. (c). The docking pose of ligand 3p in the S1. (d). Ligand–receptor interaction
diagram showing the major hot spot residues of S1 with compound 3p.
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would be an approach for the assessment of molecular recog-
nition (Unione et al., 2014).
2.2. Chemistry
The curcumin analogues (3a–s) described in the study are shown
in Table 2 and the reaction sequence for the synthesis is summa-
rized in Scheme 1. The synthesis of curcumin analogues was
accomplished in four parts. 1,7-Bis(4-hydroxy-3-methoxyphe-
nyl)hepta-1,6-diene-3,5-dione (curcumin, 1) and substituted
phenyl semicarbazide/hydrazide/urea/thiourea/ semicar-
bazide/thiosemicarbazide (2a–s) was reﬂuxed in glacial acetic
acid to obtain the 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(sub-
stituted phenyl)-1H-pyrazole-1-carboxamide/ carbothioamide
analogues (3a–e, 3r, 3s), 3,5-bis(4-hydroxy-3-methylstyryl)-
1H-pyrazole-1-yl(substituted phenyl)methanone analogues
(3f–o), and pyrimidine analogues (3p–q). We have reported
the chemistry of 8 compounds earlier while 5 compounds were
reported elsewhere (Ahsan et al., 2013; Lal et al., 2012; SahuPlease cite this article in press as: Balaji, S.N. et al., Molecular modelling, synthesis,
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.011et al., 2012). In the present investigation we report herein 19
compounds including 6 new curcumin analogues.
2.3. Antimalarial activity
The schizonticidal and parasiticidal activity of synthetic cur-
cumin analogues were determined as described previously
(Parveen et al., 2013). The schizonticidal activity of the cur-
cumin analogues showed IC50 of 1.48–23.09 lM. The com-
pound 3a showed maximum activity (IC50; 9.87 ± 2.21 lM)
among carboxamide analogues (3a–e). The compound 3l
showed maximum activity (IC50; 4.21 ± 0.62 lM) among the
methanone analogues (3f–o). The compound 3p was found
to be the most active compound with IC50 of
1.48 ± 0.10 lM, followed by the compound 3l with IC50 of
4.21 ± 0.62 lM. The schizonticidal activity of the compounds
(3a–s) is given in Table 2. The minimum killing concentration
(MKC) was the concentration of the compounds required to
kill the parasite present in the culture and is given in
Table 2. The MKC of the compounds range between 3.87and antimalarial potentials of curcumin analogues containing heterocyclic ring.
Table 2 Antimalarial activity of curcumin analogues (3a–s).
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Compound Ar//X Schizonticidal Activity IC50 (lM± SD) Nature of inhibition MKC (lM± SD)
3a
F
9.87 ± 2.21 parasiticidal 8.17 ± 0.78
3b
Cl
10.54 ± 0.67 parasiticidal 10.81 ± 1.41
3c
Br
22.47 ± 1.72 parasiticidal 11.18 ± 2.11
3d
Cl
9.88 ± 0.11 parasiticidal 4.18 ± 0.08
3e 11.99 ± 1.62 parasiticidal 14.75 ± 0.06
3f 19.23 ± 0.34 parasiticidal 14.53 ± 2.05
3g
Cl
8.03 ± 0.26 parasiticidal 13.48 ± 0.0.73
3h
Cl
19.72 ± 2.05 parasiticidal 19.86 ± 0.66
3i
Br
10.77 ± 2.26 parasiticidal 8.24 ± 0.27
3j
O
9.71 ± 0.14 parasiticidal 11.77 ± 0.22
3k
NH2
4.59 ± 0.16 parasiticidal 8.54 ± 0.06
3l
N
4.21 ± 0.62 parasiticidal 13.06 ± 0.04
3m
S
9.36 ± 0.53 parasiticidal 8.80 ± 1.41
3n 10.73 ± 1.66 parasiticidal 10.62 ± 0.19
3o
O
5.64 ± 0.72 parasiticidal 8.99 ± 0.90
3p O 1.48 ± 0.10 parasiticidal 3.87 ± 0.36
3q S 13.05 ± 3.03 parasiticidal 6.27 ± 0.09
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Table 2 (continued)
Compound Ar//X Schizonticidal Activity IC50 (lM± SD) Nature of inhibition MKC (lM± SD)
3r O 12.17 ± 0.81 parasiticidal 25.35 ± 1.44
3s S 23.09 ± 3.59 parasiticidal 24.70 ± 1.39
Chloroquine – 0.078 ± 0.012a – –
A dash (–) indicates activity not done.
a Activity reported (Parveen et al., 2013).
Scheme 1 Protocol for the synthesis of curcumin analogues (3a–s).
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with MKC of 3.87 ± 0.36 lM, followed by compound 3d with
MKC of 4.18 ± 0.08 lM. All the curcumin analogues (3a–s)
showed parasiticidal activity. The structure activity relation-
ship (SAR) was established with the antimalarial data showed
that among carboxamide analogues (3a–e), 4-ﬂuoro substitu-
tion is more favourable than 2-chloro, 4-chloro and 4-bromo,
while 2-chloro substitution showed maximum MKC than 4-
ﬂuoro, 4-chloro and 4-bromo substitution in the aromatic ring.
The antimalarial activity among methanone derivatives (3f–o)
showed that substituted aromatic ring showed maximum activ-
ity than unsubstituted aromatic ring (3f, 3n). The activity was
maximum when 4-pyridyl ring (3l) was present followed by 4-
amino (3k) substitution on aromatic ring. The curcumin ana-
logues with pyrimidine/pyrazole with carbonyl function (3p,
3r) showed maximum activity than thione function (3q, 3s).
The compound 3p could be considered as promising lead for
further optimization. Microscopic observation of infected
RBCs exposed to synthetic curcumin compounds is shown in
Fig. 2.
3. Experimental
3.1. Computational studies
The X-ray crystal structure of PfRIO-2 does not exist till date,
the homology model using the RIO2 of Archaeoglobus fulgidusPlease cite this article in press as: Balaji, S.N. et al., Molecular modelling, synthesis,
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.011(PDB: 1TQI) was reported few times (Nag et al., 2013a,b;
http://www.plasmodb.org; Parveen et al., 2013; Nag et al.,
2013a). The current experimental 3D-homology model was
built using the sequences of PDBs 1ZAO (contains the ATP
binding site and Mn ion) and AfRIO-2 by employing Prime
module (Nag et al., 2013a,b; http://www.plasmodb.org;
Parveen et al., 2013; Nag et al., 2013a). The natural bound
ligand along with Mn ion placed at functional site of the 3D
model by superimposition of model and AfRIO2 co-crystal
complex. The ﬁnal model was then prepared with all necessary
parameters using the protein preparation wizard with default
parameters. The experimental model contains the metal ions
(divalent) and ATP complex. All the chemical structures of
the ligands were drawn using the ACD chemsketch and saved
as mol. ﬁles and imported in Maestro and prepared by using
the Ligprep. Further XP protocol implemented in Glide was
employed for the ligand docking studies. The homology model
developed must be validated for its quality; the current model
was validated using the online server RAMPAGE, it gives the
quality of the structure. The Ramachandran plot of current
model exhibited that, 93.2% of the residues were present in
the favoured region, 5.0% were in allowed region and 1.8%
in outlier region. The available co-crystal structures of the
RIO-2 exhibited the binding site of the ATP along with Mn
ions only, we adopted the sitemap analysis tool of the
Schrodinger LLC in order identify the possible binding site.
The possible four various binding regions were identiﬁedand antimalarial potentials of curcumin analogues containing heterocyclic ring.
3a
3p
3e
3k
3l
3m
Figure 2 Microscopic observation of infected RBCs exposed to synthetic curcumin compounds. The parasite in the untreated condition
(‘‘Control’’) is exhibiting healthy parasite with different blood stages. The parasite in the treated condition (‘‘Treated’’) is either halting at
ring stage or giving dead parasites. Washing with complete media to remove compounds (‘‘Washed, sub-culture’’) and sub-culturing of
parasite indicate that most of the compounds are parasiticidal with no infected cells or dead parasites (parasite without cell membrane).
6 S.N. Balaji et al.through it. Among them the ﬂexible loop regions was selected
for further processes (Nag et al., 2013a,b; www.plasmodb.org;
Parveen et al., 2013; Nag et al., 2013a). The selected site was
employed for the receptor grid generation (Fig. 1a and b).Please cite this article in press as: Balaji, S.N. et al., Molecular modelling, synthesis,
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.0113.2. Chemistry
All chemicals were supplied by E. Merck (Germany), Konark
Herbal (India) and S. D. Fine Chemicals (India). Meltingand antimalarial potentials of curcumin analogues containing heterocyclic ring.
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uncorrected. Purity of the compounds was checked by elemen-
tal analysis and the progress of reactions was monitored by
TLC plates (silica gel G) using mobile phase, hexane: ethylac-
etate (6:4), and the spots were identiﬁed by iodine vapours or
UV light. IR spectra were obtained on a Schimadzu 8201 PC,
FT-IR spectrometer (KBr pellets). 1H NMR spectra were
recorded on a Bruker AC 300/400 MHz spectrometer using
TMS as internal standard in DMSO. Mass spectra were
recorded on a Bruker Esquire LCMS using ESI and elemental
analyses were performed on Perkin–Elmer 2400 Elemental
Analyzer.
3.3. General method for the synthesis of 3,5-bis(4-hydroxy-3-
methylstyryl)-N-(substituted phenyl)-1H-pyrazole-1-
carboxamide analogues (3a–e)
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
(1) (0.005 mol) and substituted phenyl semicarbazide (2a–e)
(0.005 mol) were reﬂuxed in glacial acetic acid for 12 h
(Ahsan et al., 2013). The excess of solvent was removed under
reduced pressure and then the reaction mixture was poured
into the crushed ice. The solid mass was ﬁltered, washed, dried
and recrystallized with ethanol furnished the title 3,5-bis(4-hy-
droxy-3-methylstyryl)-N-(substitutedphenyl)-1H-pyrazole-1-
carboxamide analogues (3a-e).
3.3.1. 3,5-Bis(4-hydroxy-3-methylstyryl)-N-(4-ﬂuorophenyl)-
1H-pyrazole-1-carboxamide (3a)
M.p. 70 C; yield 72% (Ahsan et al., 2013).
3.3.2. 3,5-Bis(4-hydroxy-3-methylstyryl)-N-(4-chlorophenyl)-
1H-pyrazole-1-carboxamide (3b)
M.p. 78 C; yield 66% (Ahsan et al., 2013).
3.3.3. 3,5-Bis(4-hydroxy-3-methylstyryl)-N-(4-bromophenyl)-
1H-pyrazole-1-carboxamide (3c)
M.p. 136 C; yield 74% (Ahsan et al., 2013).
3.3.4. 3,5-Bis(4-hydroxy-3-methylstyryl)-N-(2-chlorophenyl)-
1H-pyrazole-1-carboxamide (3d)
M.p. 92 C; yield 76% (Ahsan et al., 2013).
3.3.5. 3,5-Bis(4-hydroxy-3-methylstyryl)-N-(2-methylphenyl)-
1H-pyrazole-1-carboxamide (3e)
M.p. 98 C; yield 7% (Ahsan et al., 2013).
3.4. General method for the synthesis of 3,5-bis(4-hydroxy-3-
methylstyryl)-1H-pyrazole-1-yl(substituted phenyl)methanone
analogues (3f–o)
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
(1) (0.005 mol) and substituted phenyl hydrazide (2f–o)
(0.005 mol) were reﬂuxed in glacial acetic acid for 12 h. The
excess of solvent was removed under reduced pressure and
then the reaction mixture was poured into the crushed ice.
The solid mass was ﬁltered, washed, dried and recrystallized
with ethanol furnished the title 3,5-bis(4-hydroxy-3-methyl-
styryl)-1H-pyrazole-1yl(substituted phenyl)methanone ana-
logues (3f–o) (Ahsan et al., 2013).Please cite this article in press as: Balaji, S.N. et al., Molecular modelling, synthesis,
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.0113.4.1. 3,5-Bis(4-hydroxy-3-methoxystyryl)-1H-pyrazole-1-
yl(phenyl)methanone (3f)
M.p. 110 C; yield 84% (Ahsan et al., 2013).
3.4.2. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-(2-
chlorophenyl)methanone (3g)
M.p. 168–170 C; yield 74%; IR (KBr) cm1: 3412 (OH), 1751
(C‚O), 1569 (C‚N), 1329 (CAN), 699 (CACl). 1H NMR
(400 MHz, DMSO-d6): d 3.83 (6H, s, OCH3), 6.61 (1H, s,
CH‚C), 6.76 (2H, d, J = 12.1 Hz, CH and CH), 6.90 (2H,
d, J= 12.1 Hz, CH and CH), 6.94–8.17 (10H, m, ArH), 9.15
(2H, s, OH); m/z= 503.0 (M+). Cal/Ana: [C (66.85) 66.87
H (4.63) 4.61 N (5.55) 5.57].
3.4.3. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-(4-
chlorophenyl)methanone (3h)
M.p. 160–162 C; yield 78%; IR (KBr) cm1: 3406 (OH), 1745
(C‚O), 1562 (C‚N), 1337 (CAN), 698 (CACl). 1H NMR
(400 MHz, DMSO-d6): d 3.83 (6H, s, OCH3), 6.61 (1H, s,
CH‚C), 6.75 (2H, d, J = 11.6 Hz, CH and CH), 6.91 (2H,
d, J= 11.6 Hz, CH and CH), 6.93–7.89 (10H, m, ArH), 9.14
(2H, s, OH), 9.89 (1H, s, OH); m/z= 503.0 (M+). Cal/Ana:
[C (66.84) 66.87 H (4.63) 4.61 N (5.54) 5.57].
3.4.4. 3,5-Bis(4-hydroxy-3-methoxystyryl)-1H-pyrazole-1-
yl(2-bromophenyl)methanone (3i)
M.p. 288 C; yield 76% (Ahsan et al., 2013).
3.4.5. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-(4-
methoxyphenyl)methanone (3j)
M.p. 128–130 C; yield 74%; IR (KBr) cm1: 3407 (OH), 1745
(C‚O), 1561 (C‚N), 1334 (CAN), 745 (CACl). 1H NMR
(400 MHz, DMSO-d6): d 3.83 (9H, s, OCH3), 6.61 (1H, s,
CH‚C), 6.76 (2H, d, J = 12.2 Hz, CH and CH), 6.92 (2H,
d, J= 12.2 Hz, CH and CH), 6.92–7.92 (10H, m, ArH), 9.15
(1H, s, OH), 10.28 (1H, s, OH). 13C NMR (100 MHz,
DMSO-d6): d 55.9, 56.2, 107.7, 112.0, 114.8, 116.8, 120.1,
122.9, 123.6, 128.8, 130.9, 133.4, 133.9, 144.9, 147.3, 151.3,
165.1, 166.5; m/z= 499.1 (M+). Cal/Ana: [C (69.85) 69.87
H (5.24) 5.26 N (5.65) 5.62].
3.4.6. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-(4-
aminophenyl)methanone (3k)
M.p. 215–217 C (reported), 212–214 C (found); yield 71%
(Sahu et al., 2012).
3.4.7. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-
(pyrid-4-yl)methanone (3l)
M.p. 105–106 C(reported), 104–106 C (found); yield 71%
(Sahu et al., 2012).
3.4.8. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-(2-
thiophenyl)methanone (3m)
M.p. 120–122 C; yield 65%; IR (KBr) cm1: 3396 (OH), 1735
(C‚O), 1563 (C‚N), 1337 (CAN). 1H NMR (400 MHz,
DMSO-d6): d 3.83 (6H, s, OCH3), 6.61 (1H, s, CH‚C), 6.76
(2H, d, J = 12.8 Hz, CH and CH), 6.89 (2H, d, J= 12.8 Hz,
CH and CH), 6.92–7.88 (9H, m, ArH), 10.53 (2H, s, OH);and antimalarial potentials of curcumin analogues containing heterocyclic ring.
8 S.N. Balaji et al.m/z= 475.1 (M+). Cal/Ana: [C (65.84) 65.81 H (4.65) 4.67 N
(5.94) 5.90].
3.4.9. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-
(phenyl)ethanone (3n)
M.p. 138–140 C; yield 82%; IR (KBr) cm1: 3401 (OH), 1751
(C‚O), 1565 (C‚N), 1338 (CAN). 1H NMR (400 MHz,
DMSO-d6): d 3.66 (2H, s, CH2), 3.83 (6H, s, OCH3), 6.61
(1H, s, CH‚C), 6.76 (2H, d, J = 11.8 Hz, CH and CH),
6.89 (2H, d, J= 11.8 Hz, CH and CH), 6.94–7.81 (11H, m,
ArH), 9.15 (2H, s, OH); m/z= 482.6 (M+). Cal/Ana: [C
(72.14) 72.18 H (5.47) 5.43 N (5.79) 5.81].
3.4.10. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-yl-
(phenoxyl)methanone (3o)
M.p. 130–132 C; yield 76%; IR (KBr) cm1: 3402 (OH), 1755
(C‚O), 1569 (C‚N), 1334 (CAN), 745 (CACl). 1H NMR
(400 MHz, DMSO-d6): d 3.79 (2H, s, OCH2), 3.83 (6H, s,
OCH3), 6.61 (1H, s, CH‚C), 6.76 (2H, d, J = 11.8 Hz, CH
and CH), 6.90 (2H, d, J= 11.8 Hz, CH and CH), 6.94–7.38
(10H, m, ArH), 9.15 (2H, s, OH); m/z= 499.1 (M+). Cal/
Ana: [C (69.84) 69.87 H (5.25) 5.26 N (5.64) 5.62].
3.5. General method for the synthesis of dihydropyrimidine
analogues (3p and 3q)
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
(1) (0.005 mol) and urea/thiourea (2p–q) (0.005 mol) were
reﬂuxed in glacial acetic acid for 12 h. The excess of solvent
was removed under reduced pressure and then the reaction
mixture was poured into the crushed ice. The solid mass was
ﬁltered, washed, dried and recrystallized with ethanol fur-
nished the title 3,5-bis(4-hydroxy-3-methylstyryl)-N-(substitut-
edphenyl)-1H-pyrazole-1-carboxamide analogues (3p–q)
(Ahsan et al., 2013).
3.5.1. 4,6-Bis(4-hydroxy-3-methoxystyryl)pyrimidine-2(1H)-
one (3p)
M.p. 104 C; yield 72% (Ahsan et al., 2013).
3.5.2. 4,6-Bis(4-hydroxy-3-methoxystyryl)pyrimidine-2(1H)-
thione (3q)
M.p. 102–104 C; yield 75% (Ahsan et al., 2013).
3.6. General method for the synthesis of 3,5-bis(4-hydroxy-3-
methylstyryl)-1H-pyrazole-1-carboxamide/carbothiamide
analogues (3r and 3s)
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
(1) (0.005 mol) and semicarbazide/thiosemicarbazide (2r–s)
(0.005 mol) were reﬂuxed in glacial acetic acid (AcOH) for
12 h. The progress of reaction was monitored throughout by
TLC plates (silica gel G) using mobile phase, hexane: ethylac-
etate (6:4), and the spots were identiﬁed by iodine vapours or
UV light. The excess of solvent was removed under reduced
pressure and then the reaction mixture was then poured into
the crushed ice. The solid mass was ﬁltered, washed, dried
and recrystallized with ethanol furnished the title of 3,
5-bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-carboxamide/
carbothioamide analogues (3r and 3s).Please cite this article in press as: Balaji, S.N. et al., Molecular modelling, synthesis,
Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.04.0113.6.1. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-
carboxamide (3r)
M.p. 204–206 C (reported), 200–202 C (found); yield 84%
(Lal et al., 2012).
3.6.2. 3,5-Bis(4-hydroxy-3-methylstyryl)-1H-pyrazole-1-
carboxamide (3s)
M.p. 100–101 C (reported), 102 C (found); yield 79% (Lal
et al., 2012).
3.7. Antimalarial activity
The schizonticidal and parasiticidal activity of synthetic cur-
cumin analogues were determined as described previously
(Parveen et al., 2013). In brief, parasite culture was treated
with D-sorbitol and then ring stage parasite incubated with
different concentration of test compounds. After 42 h incuba-
tion, smear was prepared and stained with Giemsa stain to
monitor the maturation of ring stage parasites into schizonts.
To determine the nature of parasite growth inhibition (para-
sitostatic/parasiticidal), the compounds were removed and
the cultures were washed three times with albumax II free
RPMI-1640 and incubated in complete media with fresh
haematocrit for another 72 h. A thin smear was prepared,
and number of RBCs containing viable parasite was counted.
The minimum concentration of compounds giving no viable
parasite was used to calculate minimum killing concentration
(MKC) of compounds with parasiticidal activity.
4. Conclusion
All the compounds were synthesized in satisfactory yield. The
molecular modelling studies revealed that the curcumin ana-
logues completely occupied the S1 site of PfRIO-2 kinase with
different binding modes. All the synthesized compounds
showed signiﬁcant antimalarial activity with parasiticidal nat-
ure. One of the synthesized compounds (3p) with signiﬁcant
results was identiﬁed as promising lead for further studies
and drug discovery in the ﬁeld of malaria therapeutics. The
detailed studies to acquire more information are in progress
in our laboratories.
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